🇺🇸 FDA
Company

Eloxx

Eloxx Pharmaceuticals

ELOX biotech USA

Quick answer

Eloxx is a biotech company (ELOX) headquartered in ARLINGTON, MA, USA with 7 tracked pipeline programs.

Pipeline (7)

project

ELX-02

Cystic Fibrosis

Phase 2 · small_molecule · completed

2 trials project

ELX-02

Genetic Disease

Phase 2 · small_molecule · terminated

2 trials project

ELX-02

Alport Syndrome

Phase 2 · small_molecule · completed

1 trials project

Exaluren

Alport Syndrome, X-Linked

Phase 2 · small_molecule · active

1 trials project

ELX-02

Genetic Diseases

Phase 1 · small_molecule · terminated

1 trials project

ELX-02

Impaired Renal Function

Phase 1 · small_molecule · completed

1 trials project

Placebo

Genetic Disease

Phase 1 · small_molecule · completed

1 trials

Patents (6)

patent

US 11786539

Aminoglycoside derivatives and uses thereof in treating genetic disorders

Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11613551

Aminoglycoside derivatives and uses thereof in treating genetic disorders

Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11306115

Aminoglycoside derivatives and uses thereof in treating genetic disorders

Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10899785

Aminoglycoside derivatives and uses thereof in treating genetic disorders

Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10786520

Aminoglycoside derivatives and uses thereof in treating genetic disorders

Expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10576095

Use of aminoglycoside analogs in the treatment of Rett syndrome

Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)